Chapter 349 - 234: The Results Are Out: Rewards and Punishments

Chapter 349: Chapter 234: The Results Are Out: Rewards and Punishments

The Dean’s Office.

The director personally led a team to the scene.

Seeing so many high-level directors gathered together, the administration’s staff felt their scalps tingle. The scale of this situation was immense; no wonder the director had led a team here overnight.

Normally, the relevant personnel would make a formal visit themselves. It was rare for the director to come in person.

The director looked at the crowd, and a moment later, the young Wu Ting stepped forward. The others had intentionally gathered around him, making him the center of attention.

As the host, Dean Liu Rong personally made the introduction for Wu Ting.

"Director Song, this is the head of the research team behind the report and complaint, Director Wu Ting."

"He is an associate chief physician from the Hepatic Tumor Surgery department at Fan City First Hospital. While conducting clinical diagnoses with his colleague, Director Zhang Heng, he inadvertently discovered that Pfizer’s new drug, Sorafenib, has severe toxic side effects."

"For a drug that has been FDA-certified and is already sold in major hospitals and pharmacies across our country, the emergence of such severe toxic side effects is a critical issue."

"This is undoubtedly a humiliation for our nation’s medical sector and a ruthless endangerment of the patients suffering from related diseases!"

"After discovering the new drug’s anomaly, Wu Ting’s team invested significant manpower and resources. They mobilized teams from relevant departments in various hospitals across the Yangtze River Delta, centered around the platforms of major hospitals in Jin Province. They integrated and analyzed a vast number of clinical cases to arrive at a rigorous, truthful, and reliable conclusion."

"In addition to the clinical studies, we also completed animal toxicity tests in the lab. These prove that Pfizer’s new drug truly does have fatal toxic side effects."

As Liu Rong finished his explanation, Director Song’s expression grew serious.

Director Song immediately began reviewing Wu Ting’s paper and the data provided by Zhang Heng and Jia Jun.

After reading it, Director Song was furious!

Director Song immediately passed the relevant materials to the accompanying staff members to circulate among themselves.

The detailed data, the paper’s rigorous reasoning, the complete chain of evidence, and the joint confirmation from the top experts in the relevant medical fields who were present—with all this, Director Song immediately formulated a comprehensive plan.

"Director Wu, thank you and your research team for your attention to and oversight of the nation’s medication safety. Our administration now has a full and deep understanding of your paper and research findings."

"Next, I will immediately return to convene a meeting with the relevant departments to determine the penalties and sanctions against Pfizer Pharmaceutical!"

"I will definitely ensure a proper resolution for all the patients and their families, for Wu Ting’s team which made this significant contribution, and for all the directors here who have worked together to protect the lives of the people of Jin Country!"

"In addition to penalizing Pfizer, we will also commend and reward the teams and individuals who contributed to this report and complaint!"

With ironclad evidence in hand, Director Song did not linger and immediately led his team back to the administration’s headquarters.

After Director Song left, the various high-level directors also prepared to depart.

Liu Rong took this opportunity to once again mention to the directors that Wu Ting was preparing to hold a press conference during a break in the upcoming workshop. After getting to know Wu Ting, these senior directors all expressed their goodwill and support.

They were also looking forward to Wu Ting’s presentation at the conference.

"Director Wu, we’ll see you at the World Health Organization Western Pacific Region’s workshop on Clinical Practice Guidelines for Traditional Medicine!"

Some of the directors attending the meeting also learned from Liu Rong that Wu Ting’s team would be presenting at the clinical guidelines workshop, which made them admire and anticipate it even more.

Wu Ting exchanged contact information with these directors before bidding them farewell one by one.

...

...

The editorial office of The Lancet.

At the editor-in-chief’s request, all four senior executive editors (editors-in-chief) and two international executive editors joined the meeting via video conference. It was a rare, high-level discussion.

The Lancet is an independent, comprehensive medical journal, internationally recognized as one of the four great general medical journals.

The Lancet is a credible source of top-tier clinical, public health, and global health knowledge. It ranks first among 167 general and internal medicine journals worldwide, with a recent impact factor of 168.9!

The fact that it could attract the attention of a top-tier journal like The Lancet demonstrated the immense significance of Wu Ting’s paper.

The types of articles published in The Lancet include Research Articles, Randomized Controlled Trials, and more...

And Wu Ting’s paper was a perfect World Report!

Its challenge to authorities like Pfizer and the FDA, and its focus on and concern for the medical well-being of all humanity, perfectly aligned with The Lancet’s mission statement:

To transmit knowledge; to constantly update; to share knowledge; to be independent and just; to be globally oriented; to dare to criticize and debate; to make medicine a culture.

A fighting spirit is fused into the very soul of The Lancet, and as soon as Wu Ting’s paper appeared, it won the unanimous support of all the editors!

"A Clinical Study on the Fatal Toxic Side Effects of Pfizer’s New Drug Sorafenib and a Discussion on the Authority of FDA Certification" received a unanimous vote of approval from all senior editors!

The deadline for The Lancet’s newest issue was imminent. Faced with this breaking story, the editor-in-chief made a proposal, which all the chief editors approved.

In an unprecedented move, they bumped Wu Ting’s paper to the front of the queue, replacing the one that was originally scheduled.

Everyone’s motivation was the same: the sooner the paper was published, the sooner it would capture the world’s attention, and the sooner the poisoning of patients by this drug with fatal toxic side effects could be stopped.